- Home
- Publications
- Publication Search
- Publication Details
Title
Cancer of the ovary, fallopian tube, and peritoneum
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Volume 143, Issue -, Pages 59-78
Publisher
Wiley
Online
2018-10-11
DOI
10.1002/ijgo.12614
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Screening for Ovarian Cancer
- (2018) et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
- (2018) Willemien J. van Driel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeted therapy for gynecologic cancers: Toward the era of precision medicine
- (2018) Partha Basu et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
- (2017) Amanda N. Fader et al. GYNECOLOGIC ONCOLOGY
- Prognostic Role of Histological Tumor Regression in Patients Receiving Neoadjuvant Chemotherapy for High-Grade Serous Tubo-ovarian Carcinoma
- (2017) Edwina Coghlan et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hormonal Maintenance Therapy for Women With Low-Grade Serous Cancer of the Ovary or Peritoneum
- (2017) David M. Gershenson et al. JOURNAL OF CLINICAL ONCOLOGY
- Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Robert L Coleman et al. LANCET
- Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial
- (2017) Elizabeth M Swisher et al. LANCET ONCOLOGY
- Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial
- (2017) Eric Pujade-Lauraine et al. LANCET ONCOLOGY
- Operability and chemotherapy responsiveness in advanced low-grade serous ovarian cancer. An analysis of the AGO Study Group metadatabase
- (2016) Jacek P. Grabowski et al. GYNECOLOGIC ONCOLOGY
- Weekly vs. Every-3-Week Paclitaxel and Carboplatin for Ovarian Cancer
- (2016) John K. Chan et al. NEW ENGLAND JOURNAL OF MEDICINE
- Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer
- (2016) Mansoor R. Mirza et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inherited Mutations in Women With Ovarian Carcinoma
- (2016) Barbara M. Norquist et al. JAMA Oncology
- Incidental Nonuterine High-grade Serous Carcinomas Arise in the Fallopian Tube in Most Cases
- (2015) C. Blake Gilks et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Neoadjuvant chemotherapy in gynaecological cancers – Implications for staging
- (2015) Lalit Kumar et al. BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY
- Survival differences of Asian and Caucasian epithelial ovarian cancer patients in the United States
- (2015) Katherine C. Fuh et al. GYNECOLOGIC ONCOLOGY
- Chemotherapy Response Score: Development and Validation of a System to Quantify Histopathologic Response to Neoadjuvant Chemotherapy in Tubo-Ovarian High-Grade Serous Carcinoma
- (2015) Steffen Böhm et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib Monotherapy in Patients With Advanced Cancer and a GermlineBRCA1/2Mutation
- (2015) Bella Kaufman et al. JOURNAL OF CLINICAL ONCOLOGY
- Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial
- (2015) Sean Kehoe et al. LANCET
- Committee Opinion No. 620
- (2015) OBSTETRICS AND GYNECOLOGY
- Olaparib maintenance therapy in patients with platinum-sensitive relapsed serous ovarian cancer: a preplanned retrospective analysis of outcomes by BRCA status in a randomised phase 2 trial
- (2014) Jonathan Ledermann et al. LANCET ONCOLOGY
- Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial
- (2014) Sandro Pignata et al. LANCET ONCOLOGY
- Neo-adjuvant chemotherapy in the treatment of advanced malignant germ cell tumors of ovary
- (2013) Shobhana Talukdar et al. GYNECOLOGIC ONCOLOGY
- Long-term results of dose-dense paclitaxel and carboplatin versus conventional paclitaxel and carboplatin for treatment of advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer (JGOG 3016): a randomised, controlled, open-label trial
- (2013) Noriyuki Katsumata et al. LANCET ONCOLOGY
- Final overall survival results of phase III GCIG CALYPSO trial of pegylated liposomal doxorubicin and carboplatin vs paclitaxel and carboplatin in platinum-sensitive ovarian cancer patients
- (2012) U Wagner et al. BRITISH JOURNAL OF CANCER
- Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum
- (2012) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- Randomized, Open-Label, Phase III Study Comparing Patupilone (EPO906) With Pegylated Liposomal Doxorubicin in Platinum-Refractory or -Resistant Patients With Recurrent Epithelial Ovarian, Primary Fallopian Tube, or Primary Peritoneal Cancer
- (2012) Nicoletta Colombo et al. JOURNAL OF CLINICAL ONCOLOGY
- OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
- (2012) Carol Aghajanian et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project
- (2012) Lucy Gilbert et al. LANCET ONCOLOGY
- Olaparib Maintenance Therapy in Platinum-Sensitive Relapsed Ovarian Cancer
- (2012) Jonathan Ledermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cancer statistics, 2011
- (2011) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Reclassification of serous ovarian carcinoma by a 2-tier system
- (2011) Diane C. Bodurka et al. CANCER
- Recommendations of the Fertility Task Force of the European Society of Gynecologic Oncology About the Conservative Management of Ovarian Malignant Tumors
- (2011) Philippe Morice et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Clinical Trials in Recurrent Ovarian Cancer
- (2011) Michael Friedlander et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect of Screening on Ovarian Cancer Mortality
- (2011) Saundra S. Buys JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reducing Time to Diagnosis Does Not Improve Outcomes for Women With Symptomatic Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group
- (2011) Christina M. Nagle et al. JOURNAL OF CLINICAL ONCOLOGY
- Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
- (2011) Sandro Pignata et al. JOURNAL OF CLINICAL ONCOLOGY
- Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma
- (2011) Robert A Soslow et al. MODERN PATHOLOGY
- Incorporation of Bevacizumab in the Primary Treatment of Ovarian Cancer
- (2011) Robert A. Burger et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Phase 3 Trial of Bevacizumab in Ovarian Cancer
- (2011) Timothy J. Perren et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- BRAF Mutation Is Rare in Advanced-Stage Low-Grade Ovarian Serous Carcinomas
- (2010) Kwong-Kwok Wong et al. AMERICAN JOURNAL OF PATHOLOGY
- Current Update on Borderline Ovarian Neoplasms
- (2010) Neeraj Lalwani et al. AMERICAN JOURNAL OF ROENTGENOLOGY
- Patterns of recurrence and role of adjuvant chemotherapy in stage II–IV serous ovarian borderline tumors
- (2010) Karin K. Shih et al. GYNECOLOGIC ONCOLOGY
- Randomized phase III trial of tamoxifen versus thalidomide in women with biochemical-recurrent-only epithelial ovarian, fallopian tube or primary peritoneal carcinoma after a complete response to first-line platinum/taxane chemotherapy with an evaluation of serum vascular endothelial growth factor (VEGF): A Gynecologic Oncology Group Study
- (2010) Jean A. Hurteau et al. GYNECOLOGIC ONCOLOGY
- The Role of Inhibins B and Antimüllerian Hormone for Diagnosis and Follow-up of Granulosa Cell Tumors
- (2010) Inge Geerts et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Lymph Node-Positive Stage IIIC Ovarian Cancer
- (2010) Jonathan S. Berek INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Trabectedin Plus Pegylated Liposomal Doxorubicin in Recurrent Ovarian Cancer
- (2010) Bradley J. Monk et al. JOURNAL OF CLINICAL ONCOLOGY
- Early versus delayed treatment of relapsed ovarian cancer (MRC OV05/EORTC 55955): a randomised trial
- (2010) Gordon JS Rustin et al. LANCET
- High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression
- (2010) Michael H Roh et al. MODERN PATHOLOGY
- Calculator for ovarian carcinoma subtype prediction
- (2010) Steve E Kalloger et al. MODERN PATHOLOGY
- Testicular germ cell tumors: pathogenesis, diagnosis and treatment
- (2010) Christian Winter et al. Nature Reviews Endocrinology
- Neoadjuvant Chemotherapy or Primary Surgery in Stage IIIC or IV Ovarian Cancer
- (2010) Ignace Vergote et al. NEW ENGLAND JOURNAL OF MEDICINE
- Defining the Cut Point Between Low-grade and High-grade Ovarian Serous Carcinomas
- (2009) Ayse Ayhan et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Histological response is not a prognostic factor after neoadjuvant chemotherapy in advanced-stage ovarian cancer with no residual disease
- (2009) Jean-Guillaume Ferron et al. European Journal of Obstetrics & Gynecology and Reproductive Biology
- Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
- (2009) David M. Gershenson et al. GYNECOLOGIC ONCOLOGY
- The potential benefit of 6 vs. 3 cycles of chemotherapy in subsets of women with early-stage high-risk epithelial ovarian cancer: An exploratory analysis of a Gynecologic Oncology Group study
- (2009) John K. Chan et al. GYNECOLOGIC ONCOLOGY
- Evaluation of New Platinum-Based Treatment Regimens in Advanced-Stage Ovarian Cancer: A Phase III Trial of the Gynecologic Cancer InterGroup
- (2009) Michael A. Bookman et al. JOURNAL OF CLINICAL ONCOLOGY
- Neoadjuvant chemotherapy for low-grade serous carcinoma of the ovary or peritoneum
- (2008) Kathleen M. Schmeler et al. GYNECOLOGIC ONCOLOGY
- Growing teratoma syndrome of ovary
- (2008) Roopa Hariprasad et al. International Journal of Clinical Oncology
- New Insights Into the Pathogenesis of Serous Ovarian Cancer and Its Clinical Impact
- (2008) Keren Levanon et al. JOURNAL OF CLINICAL ONCOLOGY
- Serous Tubal Intraepithelial Carcinoma: Its Potential Role in Primary Peritoneal Serous Carcinoma and Serous Cancer Prevention
- (2008) Joseph W. Carlson et al. JOURNAL OF CLINICAL ONCOLOGY
- Combination of bleomycin, etoposide, and cisplatin for the treatment of advanced ovarian granulosa cell tumors
- (2007) P. PAUTIER et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites
- (2007) D.M. PATTERSON et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Effect ofBRCA1/2Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer
- (2007) Angela Chetrit et al. JOURNAL OF CLINICAL ONCOLOGY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started